Search research articles
Contact Us
Filters
Showing results (21-30 of 122) with videos related to
Page
of 13
Sort By:
Antiviral Therapy
|
March 16, 2017
Author reply to: Hepatitis B reactivation in chronic hepatitis C patients during treatment with ledipasvir and sofosbuvir
Edward J Gane, Robert H Hyland, Di An, et al.
Antiviral Therapy
|
July 2, 2016
Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV
Edward J Gane, Robert H Hyland, Di An, et al.
Hepatology (Baltimore, Md.)
|
November 18, 2009
Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
Savino Bruno, Mitchell L Shiffman, Stuart K Roberts, et al.
Gastroenterology
|
August 12, 2015
Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection
Edward J Gane, Robert H Hyland, Di An, et al.
Diabetes/Metabolism Research and Reviews
|
September 27, 2016
Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial
Wai Gin Lee, Rinki Murphy, John L McCall, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
March 24, 2005
Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy
Lindsay D Plank, John L McCall, Edward J Gane, et al.
Human Biology
|
October 14, 2006
Genetic diversity and linkage disequilibrium in the Polynesian population of Niue Island
William G H Abbott, Ingrid M Winship, Edward J Gane, et al.
Journal of Gastroenterology and Hepatology
|
May 11, 2007
Hepatitis E in new zealand
Harry R Dalton, Helen J Fellows, Edward J Gane, et al.
The Journal of General Virology
|
April 22, 2011
Evidence for reduced selection pressure on the hepatitis B virus core gene in hepatitis B e antigen-negative chronic hepatitis B
Brook G Warner, Peter Tsai, Allen G Rodrigo, et al.
Gastroenterology
|
March 27, 2007
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
Edward J Gane, Peter W Angus, Simone Strasser, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 122) with videos related to
Sort By:
Page
of 13
Antiviral Therapy
|
March 16, 2017
Author reply to: Hepatitis B reactivation in chronic hepatitis C patients during treatment with ledipasvir and sofosbuvir
Edward J Gane, Robert H Hyland, Di An, et al.
Antiviral Therapy
|
July 2, 2016
Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV
Edward J Gane, Robert H Hyland, Di An, et al.
Hepatology (Baltimore, Md.)
|
November 18, 2009
Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
Savino Bruno, Mitchell L Shiffman, Stuart K Roberts, et al.
Gastroenterology
|
August 12, 2015
Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection
Edward J Gane, Robert H Hyland, Di An, et al.
Diabetes/Metabolism Research and Reviews
|
September 27, 2016
Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial
Wai Gin Lee, Rinki Murphy, John L McCall, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
March 24, 2005
Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy
Lindsay D Plank, John L McCall, Edward J Gane, et al.
Human Biology
|
October 14, 2006
Genetic diversity and linkage disequilibrium in the Polynesian population of Niue Island
William G H Abbott, Ingrid M Winship, Edward J Gane, et al.
Journal of Gastroenterology and Hepatology
|
May 11, 2007
Hepatitis E in new zealand
Harry R Dalton, Helen J Fellows, Edward J Gane, et al.
The Journal of General Virology
|
April 22, 2011
Evidence for reduced selection pressure on the hepatitis B virus core gene in hepatitis B e antigen-negative chronic hepatitis B
Brook G Warner, Peter Tsai, Allen G Rodrigo, et al.
Gastroenterology
|
March 27, 2007
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
Edward J Gane, Peter W Angus, Simone Strasser, et al.
Page
of 13